ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

Source link : https://newshealth.biz/health-news/adc-pertuzumab-promising-as-new-standard-in-her2-positive-metastatic-breast-cancer/ (MedPage Today) — CHICAGO — First-line trastuzumab deruxtecan (T-DXd) combined with pertuzumab (Perjeta) improved progression-free survival (PFS) in HER2-positive locally advanced or metastatic breast cancer, according to the DESTINY-Breast09… Source link…

Measles Update: Where Are We Now?

Source link : https://newshealth.biz/health-news/measles-update-where-are-we-now/ For 30 years, pediatrician Tammy Camp, MD, of Lubbock, Texas, never once encountered a case of measles on the job. Now, that’s all changed. As she told colleagues last week, that’s…

Teleneurology Bests Onboard Stroke Care Model

Source link : https://newshealth.biz/health-news/teleneurology-bests-onboard-stroke-care-model/ HELSINKI, Finland — Using telemedicine-based neurologist assessments in mobile stroke units proves to be safer and more resource-efficient than using traditional models in which a neurologist is on board the ambulance,…

Home Healthcare Common for People With Dementia

Source link : https://newshealth.biz/health-news/home-healthcare-common-for-people-with-dementia/ TOPLINE: The use of home healthcare services is common among people with dementia, especially for community-initiated care, a new analysis of Medicare data showed. Between 2010 and 2019, use of community-initiated…

ACURATE Heart Valves Halted After Consequential Study

Source link : https://newshealth.biz/health-news/acurate-heart-valves-halted-after-consequential-study/ Boston Scientific has discontinued production of its ACURATE neo2 heart valves following the release of data showing the devices were linked to higher rates of all-cause death, stroke, and rehospitalization than…

Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus

Source link : https://newshealth.biz/health-news/remission-attaining-cv-risk-targets-drops-cvd-risk-in-lupus/ TOPLINE: Patients with systemic lupus erythematosus (SLE) had more than double the risk for atherosclerosis progression over 10 years than healthy control individuals, but maintaining cardiovascular risk factor (CVRF) targets and…

The Genetic Counselor: Your Clinic’s Missing Link

Source link : https://newshealth.biz/health-news/the-genetic-counselor-your-clinics-missing-link/ “Prioritizing Counseling in Genetic Counseling” was a thought-provoking workshop title at the 2025 European Society of Human Genetics Conference, held May 24-27 in Milan, Italy. While it may seem obvious that…

Pharmacists warn drug shortage affecting cancer patients

Source link : https://newshealth.biz/health-news/pharmacists-warn-drug-shortage-affecting-cancer-patients/ Getty Images Pharmacists have warned that “one of the worst” examples of medicine shortages is affecting cancer patients. Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion and is required by…

Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer

Source link : https://newshealth.biz/health-news/add-on-nivolumab-extends-dfs-in-locally-advanced-head-and-neck-cancer/ (MedPage Today) — CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in certain patients with locally advanced head and neck squamous cell carcinoma (HNSCC),…

Tumor Treating Fields Boost Pancreatic Cancer Survival

Source link : https://newshealth.biz/health-news/tumor-treating-fields-boost-pancreatic-cancer-survival/ The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was associated with significantly improved overall survival in a phase 3 trial for patients with unresectable, locally…

In Pancreatic Cancer, Does New PAXG Beat Out mFOLFIRINOX?

Source link : https://newshealth.biz/health-news/in-pancreatic-cancer-does-new-paxg-beat-out-mfolfirinox/ CHICAGO — For patients with pancreatic resectable stage I-Ill pancreatic ductal adenocarcinoma (PDAC), neoadjuvant chemotherapy can help improve overall survival compared with upfront surgery. But what chemotherapy regimen provides the best…

Viral TikTok Trend for Weight Loss Is Harmful for Health

Source link : https://newshealth.biz/health-news/viral-tiktok-trend-for-weight-loss-is-harmful-for-health/ Share on Pinterest“Skinny Tok” is an extreme dieting trend on TikTok that equates thinness with health. Miodrag Ignjatovic/Getty Images “Skinny Tok,’ an extreme form of dieting that equates thinness with health,…

Colon Cancer Patients Live Longer With Exercise Prescription

Source link : https://newshealth.biz/health-news/colon-cancer-patients-live-longer-with-exercise-prescription/ (MedPage Today) — CHICAGO — A structured exercise program improved survival outcomes in patients on adjuvant chemotherapy for colon cancer, according to the CHALLENGE study. The phase III randomized trial showed…

Adjuvant Immunotherapy Ups Survival in dMMR Colon Cancer

Source link : https://newshealth.biz/health-news/adjuvant-immunotherapy-ups-survival-in-dmmr-colon-cancer/ (MedPage Today) — CHICAGO — The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer decreased by 50% in patients who received immunotherapy in addition to…

Can New Biomarker Help Identify High-Risk DLBCL Patients?

Source link : https://newshealth.biz/health-news/can-new-biomarker-help-identify-high-risk-dlbcl-patients/ For patients with diffuse large B-cell lymphoma (DLBCL), the detection of circulating tumor DNA (ctDNA) following first-line treatment is independently predictive of disease recurrence and overall survival over 2 years, suggesting…

Which Class of ER Degrader Is Better?

Source link : https://newshealth.biz/health-news/which-class-of-er-degrader-is-better/ Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), outshone the commonly used selective estrogen receptor degrader (SERD) fulvestrant in a phase 3 trial of second-line…

Does the TikTok “cure” really work?

Source link : https://newshealth.biz/health-news/does-the-tiktok-cure-really-work/ Getty Images Ruth Clegg Health and well-being reporter It’s a condition that affects more than 10 million people in the UK. It can change futures, end careers, and shrink worlds. So…

Perioperative Durvalumab Plus FLOT Boosts EFS in Resectable Gastric/GEJ Cancer

Source link : https://newshealth.biz/health-news/perioperative-durvalumab-plus-flot-boosts-efs-in-resectable-gastric-gej-cancer/ (MedPage Today) — CHICAGO — Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) compared with FLOT alone in patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma……

Romesh Ranganathan opens up about mental health struggle

Source link : https://newshealth.biz/health-news/romesh-ranganathan-opens-up-about-mental-health-struggle/ Annabel Rackham and Steven McIntosh Culture reporters BBC Ranganathan said he used running, reading and breathing exercises to help centre himself when feeling down The post Romesh Ranganathan opens up about…

Disposable vapes ban begins but will teens quit?

Source link : https://newshealth.biz/health-news/disposable-vapes-ban-begins-but-will-teens-quit/ The ban on the sale of single-use disposable vapes will come into force on Sunday across the UK, aimed at protecting children’s health and the environment. It means shops and supermarkets…

The Evidence

Source link : https://newshealth.biz/health-news/the-evidence/ Why is it so hard to understand the effects a warming world has on our health? Source link : https://www.bbc.co.uk/sounds/play/w3ct70s9 Author : Publish date : 2025-05-31 12:00:00 Copyright for syndicated content…

CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer

Source link : https://newshealth.biz/health-news/car-t-cell-therapy-boosts-pfs-in-advanced-gastric-cancer/ TOPLINE In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy significantly extended progression-free survival (PFS) compared with…

What Was Billy Joel Diagnosed With?

Source link : https://newshealth.biz/health-news/what-was-billy-joel-diagnosed-with/ (MedPage Today) — You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/115830 Author : Publish date : 2025-05-31 21:00:00 Copyright for syndicated content…

Post-Induction, Ponatinib Yields Molecular Response

Source link : https://newshealth.biz/health-news/post-induction-ponatinib-yields-molecular-response/ In the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), patients who fail to achieve initial molecular response with the third-generation tyrosine kinase inhibitor (TKI) ponatinib following induction…

UK ban on disposable vapes is going into impact

Source link : https://health365.info/uk-ban-on-disposable-vapes-is-going-into-impact/ Credit score: Pixabay/CC0 Public Area A ban on disposable vapes is going into impact throughout the United Kingdom on Sunday in a bid to offer protection to youngsters’s well being and…

A Doctor’s Bias Creeps Into the Courtroom

Source link : https://newshealth.biz/health-news/a-doctors-bias-creeps-into-the-courtroom/ (MedPage Today) — I was recently called to jury duty in Washington, D.C. I had no idea what to expect since, in our nation’s capital, jury duty could mean sitting in…

Sacituzumab or Chemo in First-Line TNBC: Which Is Better?

Source link : https://newshealth.biz/health-news/sacituzumab-or-chemo-in-first-line-tnbc-which-is-better/ Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced or metastatic triple-negative breast cancer (TNBC) compared with treatment with pembrolizumab…

Novel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line

Source link : https://newshealth.biz/health-news/novel-oral-agent-for-esr1-mutated-breast-cancer-boosts-pfs-in-second-line/ (MedPage Today) — CHICAGO — The investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant (Faslodex) in previously treated estrogen receptor (ER)-positive metastatic breast cancer patients… Source…

T-DXd Prevails in Trial of Second-Line Therapies for HER2 Gastroesophageal Cancer

Source link : https://newshealth.biz/health-news/t-dxd-prevails-in-trial-of-second-line-therapies-for-her2-gastroesophageal-cancer/ (MedPage Today) — CHICAGO — Patients with progressive HER2-positive gastroesophageal (GE) cancer lived significantly longer when they received the antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) instead of ramucirumab… Source link…

Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS

Source link : https://newshealth.biz/health-news/gene-driven-adjuvant-therapy-for-nsclc-leads-to-big-improvement-in-dfs/ (MedPage Today) — CHICAGO — Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to significantly longer disease-free survival (DFS) as compared with observation, a randomized trial showed. DFS……